The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.84% lower by 210 points at 24,845, indicating that the domestic benchmark indices are likely to make a negative start on Friday.

On Thursday, 1 August, Domestic benchmark indices S&P BSE Sensex gained 126 points or 0.15%, to end at 81,868, while the Nifty50 traded 60 points or 0.24% higher and settled at 25,011.

Here are some stocks that are likely to remain in focus on 2 August.

Quarterly Results Today: GlaxoSmithKline Pharmaceuticals, Hindustan Zinc, Kirloskar Brothers, PSP Projects, Saregama India, Sheela Foam, Sudarshan Chemical Industries, Archean Chemical Industries, CAMS, Delhivery, Dhanuka Agritech, LIC Housing Finance, Medplus Health Services, Mold-Tek Packaging, Zydus Wellness, UPL, and Titan Company are some of the prominent companies that are set to release their quarterly earnings for April-June.

Tata Motors: In its quarterly earnings for April-June, the company reported a 74% year-on-year increase in net profit to Rs 5,566 crore during the quarter from Rs 3,203 crore reported in the same quarter last year. 

JSW Infrastructure: JSW Group has announced their plans to transform its infrastructure subsidiary, JSW Infrastructure, into a complete logistics solutions provider.

Adani Enterprises: The company reported its net profit for Q1FY25 at Rs 1,454.50 crore, marking a 115.8% YoY increase against Rs 673.93 crore during the corresponding quarter of previous fiscal year. 

Infosys: The company announced that the Goods and Services Tax Department has withdrawn the pre-show cause notice after the company provided additional responses to the Directorate General of GST Intelligence’s central authority regarding the matter. 

Dabur: For the quarter ended 30 June, the company reported a 8% YoY increase in consolidated net profit to Rs 500 crore, driven by volume growth in rural markets. The revenue from operations during the quarter stood at Rs 3,349 crore, marking a 7% YoY increase from the same quarter last year. 

Sun Pharmaceutical: The pharma major reported a 40.2% YoY increase in net profit to Rs 2,835.62 crore compared to Rs  2,022.54 crore in Q1FY24. 

ITC: The company reported its net profit at Rs 5176.99 crore for the quarter ended 30 June, which is marginally lower from Rs 5190.71 crore recorded during the first quarter of the previous fiscal year.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app today and 10x your trading & investing journey!